Mediwound Ltd Earnings: Beat on EPS Despite Revenue Miss

Mediwound Ltd (MDWD) delivered mixed quarterly results on May 27, 2026, beating earnings expectations while falling short on revenue. The company reported an EPS loss of $0.23, significantly better than the expected loss of $0.67, representing a positive surprise of 65.49%.

The biotech company’s earnings performance marked a substantial improvement over analyst projections, with the actual loss per share coming in $0.44 better than estimates. This 65.49% positive surprise demonstrated better-than-expected cost management during the quarter.

However, revenue results painted a different picture, with Mediwound generating $1.48 million in quarterly revenue compared to analyst expectations of $3.18 million. This represented a significant revenue miss of 53.45%, with actual sales falling $1.70 million short of projections.

The $1.48 million in reported revenue reflected ongoing challenges in the company’s commercial execution, despite the improved bottom-line performance that helped narrow losses beyond expectations.

This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results.